hrcak mascot   Srce   HID

Stručni rad

Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide

Romano Vrabec
Zoran Vatavuk
Goran Benčić
Ivan Čima
Ognjen Zrinšćak
Zdravko Mandić

Puni tekst: engleski, pdf (436 KB) str. 161-165 preuzimanja: 297* citiraj
APA 6th Edition
Vrabec, R., Vatavuk, Z., Benčić, G., Čima, I., Zrinšćak, O. i Mandić, Z. (2007). Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide. Acta clinica Croatica, 46 (2), 161-165. Preuzeto s https://hrcak.srce.hr/13622
MLA 8th Edition
Vrabec, Romano, et al. "Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide." Acta clinica Croatica, vol. 46, br. 2, 2007, str. 161-165. https://hrcak.srce.hr/13622. Citirano 13.11.2019.
Chicago 17th Edition
Vrabec, Romano, Zoran Vatavuk, Goran Benčić, Ivan Čima, Ognjen Zrinšćak i Zdravko Mandić. "Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide." Acta clinica Croatica 46, br. 2 (2007): 161-165. https://hrcak.srce.hr/13622
Harvard
Vrabec, R., et al. (2007). 'Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide', Acta clinica Croatica, 46(2), str. 161-165. Preuzeto s: https://hrcak.srce.hr/13622 (Datum pristupa: 13.11.2019.)
Vancouver
Vrabec R, Vatavuk Z, Benčić G, Čima I, Zrinšćak O, Mandić Z. Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide. Acta clinica Croatica [Internet]. 2007 [pristupljeno 13.11.2019.];46(2):161-165. Dostupno na: https://hrcak.srce.hr/13622
IEEE
R. Vrabec, Z. Vatavuk, G. Benčić, I. Čima, O. Zrinšćak i Z. Mandić, "Choroidal Neovascularization in Age-Related Macular Degeneration Treated with Photodynamic Therapy and Intravitreal Triamcinolone Acetonide", Acta clinica Croatica, vol.46, br. 2, str. 161-165, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/13622. [Citirano: 13.11.2019.]

Sažetak
The aim of the study was to show the effect of combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in the treatment of choroidal neovascularization due to age-related macular degeneration. This retrospective, nonrandomized study included 20 patients with predominantly classic choroidal neovascularization due to age-related macular degeneration with no prior treatment. At baseline, all patients underwent ophthalmologic examination. Fluorescein angiography and optical coherent tomography were performed and analyzed. Triamcinolone acetonide, 4 mg, was intravitreally applied at 24-48 hours after standard photodynamic therapy. Follow up was scheduled at 3, 6 and 9 months. After 9 months, visual acuity improved in four, remained unchanged in 14 and decreased in two patients. In all patients, complete closure of choroidal neovascularization occurred after 9 months. At that time, a decrease in the central foveal thickness was also recorded in all patients. Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide is a safe method in the treatment of choroidal neovascularization due to age-related macular degeneration, and leads to complete closure of choroidal neovascularization. To prove these promising results, a carefully designed, randomized, controlled study in a larger group of patients is needed.

Ključne riječi
Macular degeneration complications; Macular degeneration therapy; Choroidal neovascularization etiology; Choroidal neovascularization drug therapy; Photochemotherapy

Hrčak ID: 13622

URI
https://hrcak.srce.hr/13622

[hrvatski]

Posjeta: 740 *